Home
Conditions
Relapse

Clinical trial condition

Relapse

Explore clinical trials studying Relapse. Study availability and eligibility vary by location and protocol.

59 public trials 18 recruiting studies

Refine in advanced search Browse all conditions

Relapse trial results

Not Yet Recruiting

The Safety and Efficacy of Daratumumab in Patients With Refractory Aplastic Anemia

NCT07287228

Conditions: Anemia, Anemia, Aplastic, Aplastic Anemia, +10 more
Locations: Institute of Hematology & Blood Diseases Hosptial, Chinese Academy of Medical Science and Peking Union Medical School Tianjin, Tianjin Municipality, China

View Trial Details

Not Yet Recruiting

Azacitidine Combined with Donor Lymphocyte Infusion for Acute Myeloid Leukemia Post-transplant Relapse Prevention.

NCT06754540

Conditions: Acute Myeloid Leukemia (AML), Disease Attributes, Hematologic Diseases, +10 more
Locations: Not specified

View Trial Details

Not Yet Recruiting

Allogeneic Immunotherapy of Hematological Malignancies Using Regulatory T-cell Selective Depletion

NCT06180499

Conditions: Disease Attributes, Hematologic Diseases, Hematologic Neoplasms, +9 more
Locations: Not specified

View Trial Details

Completed

Salvage Treatment With Glofitamab in R/R B-NHL: a GIMEMA-FIL Study

NCT05927558

Conditions: B-cell Non Hodgkin Lymphoma, Disease Attributes, Hemic and Lymphatic Diseases, +14 more
Locations: Ematologia Istituto Nazionale Tumori Milan, Italy

View Trial Details

Completed

Adapted RPM-08 for Substance Use Disorder in Pakistan

NCT07552623

Conditions: Chemically-Induced Disorders, Disease Attributes, Drug Abuse, +7 more
Locations: Ghamkol Decent Rehab Center Addiction Treatment Center Lahore Lahore, Punjab Province, Pakistan

View Trial Details

Completed

CD19 CAR T Cells in Patients With Relapsed or Refractory CD19 Positive B-cell Lymphoma

NCT03029338

Conditions: Disease Attributes, Hemic and Lymphatic Diseases, Immune System Diseases, +13 more
Locations: Institute of Hematology & Blood Diseases Hospital Tianjin, China

View Trial Details

Completed

Dose-Escalation Study of Oral Administration of LP-108 as Monotherapy and in Combination With Azacitidine in Patients With Relapsed or Refractory MDS, CMML, or AML

NCT04139434

Conditions: AML/MDS, CMML, Disease Attributes, +20 more
Locations: University of Michigan Ann Arbor, Michigan, United States

University of Cincinnati Cincinnati, Ohio, United States

Ohio State Comprehensive Cancer Center Columbus, Ohio, United States

MD Anderson Cancer Center Huston, Texas, United States

View Trial Details

Completed

Clinical Outcomes Following Transcutaneous Auricular Neurostimulation to Improve Relapse Prevention: A Long-term Follow-up Study

NCT05591703

Conditions: Chemically-Induced Disorders, Disease Attributes, Mental Disorders, +8 more
Locations: Betty Ford Foundation Rancho Mirage, California, United States

Hazelden Betty Ford Foundation Center City, Minnesota, United States

Hazelden Betty Ford Foundation Plymouth, Minnesota, United States

View Trial Details

Completed

TPI 287 in Patients With Refractory or Recurrent Neuroblastoma or Medulloblastoma

NCT00867568

Conditions: Disease Attributes, Glioma, Medulloblastoma, +14 more
Locations: Rady Children's Hospital San Diego, California, United States

Arnold Palmer Hospital for Children- MD Anderson Orlando, Florida, United States

Cardinal Glennon Children's Medical Center St Louis, Missouri, United States

Levine Children's Hospital Charlotte, North Carolina, United States

View Trial Details

Completed

Does the Mesh Have to be Fixed in Laparoscopic eTEP Repair of Bilateral Inguinal Hernia?

NCT06070207

Conditions: Disease Attributes, Migration of Implant, Neurologic Manifestations, +7 more
Locations: University of Health Science Van Training and Research Hospital Van, Turkey (Türkiye)

View Trial Details

Relapse

Relapse trial results

Related conditions